Thomas Clozel
TC
· France· angel
Thomas Clozel
About
Thomas Clozel is a French oncologist, entrepreneur, and angel investor — co-founder and CEO of Owkin, a scientific AI company that leverages machine learning to enhance medical research, valued at over $1 billion following Sanofi's investment in 2021. He is the son of Jean-Paul and Martine Clozel, founders of Swiss biotech Actelion. His angel investments span AI, biotech, and climate innovation.
Sector Focus
AI
Biotech
Healthcare
Climate Tech
Portfolio
Investment Activity
No timeline data for this period
Score Breakdown
13Deal Activity
0Track Record
0Visibility
0Profile
65Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Thomas Clozel?
Thomas Clozel is a French oncologist, entrepreneur, and angel investor — co-founder and CEO of Owkin, a scientific AI company that leverages machine learning to enhance medical research, valued at over $1 billion following Sanofi's investment in 2021. He is the son of Jean-Paul and Martine Clozel, founders of Swiss biotech Actelion. His angel investments span AI, biotech, and climate innovation.
What kind of firm is Thomas Clozel?
Thomas Clozel is a angel.
Where is Thomas Clozel based?
Thomas Clozel is based in France.
What sectors does Thomas Clozel focus on?
Thomas Clozel focuses on AI, Biotech, Healthcare, Climate Tech.